Investor's Business Daily on MSN7h
Schrodinger Stock Scores IBD Rating Upgrade
Schrodinger stock earned a positive adjustment to its Relative Strength (RS) Rating, from 66 to 73. Please watch the video at ...
Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...
Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...
and 120,338 matched individuals without IBD. The researchers found that during a mean follow-up of 10.5 years, 1.9% of ...
SAN FRANCISCO -- Janus kinase (JAK) inhibitors appeared to be a safe, effective option for treating inflammatory bowel ...
No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.
“In the UK, people with IBD have regular colonoscopies — a camera ... which we can predict who really is at risk of cancer will mean that we can give treatment appropriately,” Graham said.
Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, ...
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...
Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...